首页/数据集/Liposome specifications of the DDA:TDB formulations containing OVA and TLR agonists.

Liposome specifications of the DDA:TDB formulations containing OVA and TLR agonists.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_Liposome_specifications_of_the_DDA_TDB_formulations_containing_OVA_and_TLR_agonists_/332978 数据链接链接失效反馈

官方服务：

资源简介：

Liposome specifications of the DDA:TDB formulations containing OVA and TLR agonists.

应用场景：

创建时间：

2015-12-02

抗菌素耐药性

疫苗佐剂开发

Chromosomally encoded low membrane permeability and highly efficient efflux systems are major mechanisms by which Pseudomonas aeruginosa evades antibiotic actions. Our previous reports have shown that

NIAID Data Ecosystem80

Enhancing COVID-19 Vaccine Efficacy: Dual Adjuvant Strategies with TLR7/8 Agonists and Glycolipids

疫苗佐剂开发

免疫应答调控

The controlled release of immunostimulatory agents represents a promising strategy to enhance vaccine efficacy while minimizing side effects. This study aimed to improve the efficacy of the RBD-Fc-bas

Figshare2024-12-09 更新40

Developing a Next-Generation Vaccine Adjuvant System through Rational Design to Alleviate AS01 Adjuvant Deficiency

疫苗佐剂开发

免疫增强技术

Vaccine adjuvants play a crucial role in enhancing immunogenicity, with AS01 distinguishing itself due to its potent immunostimulatory properties. However, its broader application in vaccines is limit

Figshare2026-03-19 更新10

Data Sheet 1_Complement system activation in wild boar (Sus scrofa) following parenteral administration of heat-inactivated Mycobacterium bovis.xlsx

疫苗佐剂开发

动物传染病免疫模型

IntroductionDevelopment of vaccines to preserve and improve human and animal health requires effective protective antigens, delivery platforms, and adjuvants. The immunostimulant based on heat-inactiv

NIAID Data Ecosystem60

Table_2_The adjuvant effect of bacterium-like particles depends on the route of administration.xlsx

疫苗佐剂开发

黏膜免疫

Direct administration of vaccines to mucosal surfaces, such as via oral or nasal vaccination, represents an attractive alternative, or complement, to current parenteral vaccination because it has a po

NIAID Data Ecosystem30

Liposome specifications of the DDA:TDB formulations containing OVA and TLR agonists.

资源简介：

相关数据集